GlassScriptPhysician profile
Robby J Caballes
NPI 1225558141
$8,258.92
in general payments reported to CMS, 2019-2025
35 companies · $782 in 2025
The $782 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $242 · 2021: $3,291 · 2022: $1,396 · 2023: $1,720 · 2024: $697 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,152 · Travel and Lodging: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,151.51 |
| Travel and Lodging | $1,047.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $1,500.00 | 2021 | |
| Southern Edge Orthopaedics, INC. | $1,224.72 | 2021-2023 | |
| Paragon 28, INC. | $1,147.29 | 2022-2024 | Apex 3d, Portfolio, Bun-Yo-Matic |
| Depuy Synthes Sales INC. | $867.95 | 2022-2023 | Hammerlock, Na |
| Stryker Corporation | $575.49 | 2020-2025 | Ortholoc 3di Crosscheck, N/A, Infinity |
| Arthrex, INC. | $462.45 | 2025 | |
| Kerecis Limited | $229.39 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $226.27 | 2020-2023 | Grafix Pl, Renasys Go V2 Home, Pico |
| Organogenesis INC. | $196.49 | 2024-2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Next Science LLC | $191.22 | 2023 | Blastx, Xperience, Surgx |
| Treace Medical Concepts, INC. | $158.12 | 2022-2025 | |
| Boston Scientific Corporation | $128.58 | 2024 | |
| Abbvie INC. | $128.15 | 2021-2024 | |
| Horizon Therapeutics Plc | $124.99 | 2021 | |
| Anika Therapeutics, INC. | $112.49 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $109.51 | 2019 | |
| Medtronic, INC. | $108.99 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $101.67 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $85.80 | 2023 | |
| Paratek Pharmaceuticals, INC. | $85.77 | 2021-2023 | Nuzyra |
| Integra Lifesciences Corporation | $83.24 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merck Sharp & Dohme LLC | $74.20 | 2023-2024 | Pifeltro, Delstrigo, Zerbaxa |
| Bone Support INC. | $67.20 | 2020 | |
| Melinta Therapeutics, LLC | $37.58 | 2022 | |
| Bioventus LLC | $35.35 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Cumberland Pharmaceuticals, INC. | $32.02 | 2020-2021 | |
| Lifenet Health | $24.30 | 2023 | |
| Endo Pharmaceuticals INC. | $21.40 | 2019 | |
| Reprise Biomedical, INC. | $20.84 | 2024 | Miro3d |
| Merz North America, INC. | $18.84 | 2024 | |
| Amgen INC. | $17.62 | 2022 | |
| Kci USA, INC. | $16.92 | 2020 | |
| Janssen Biotech, INC. | $16.72 | 2023 | Symtuza |
| Kowa Pharmaceuticals America, INC. | $15.53 | 2023 | Seglentis |
| Hydrofera LLC | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robby Caballes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.